Enzolytics Inc (ENZC)

[Wisdom of Locke]

No one can “dump into the float”. Maturing stocks are a normal and natural process.

Restricted shares are only 400+ million, of which 300+ million are held by officers and directors. Almost all other issued shares have aged and are free floating right now.

70 million of those restricted shares are the subject of the Savov litigation. In my opinion, the restrictions on those shares will NEVER be lifted. Using math, that means less than 100 million shares (less than 4%) are even available to mature and add to the float.

Price is actually is up 800 times from summer of 2020.

ENZC rarely puts out press releases, and they tend to be technical/scientific PR’s. Very thorough, not exactly fluff.

IPF Immune is announced to be an immune booster, not a food supplement. The underlying formula is similar to ITV-1, which has been referred to as a cure by Samsung.

This morning’s press release states the ENZC position on IPF Immune: ”Enzolytics' immune modulator supports immune function by positively supporting the immune system," said Harry Zhabilov, CSO of Enzolytics, Inc. "We have devoted years to developing an immune modulator that fortifies your natural defenses.”

"When you take Enzolytics IPF Immune™, it strengthens the body's response against viruses or other pathogens," Mr. Zhabilov added. "Enzolytics IPF Immune™ mitigates the damage that the viruses can do."
Refer to comments above.

Those supposed “red flags” have all been debunked. If they were really red flags, something would have happened by now.

Joseph, the inventor of Clone-3, is one of the most valuable assets that ENZC has. All issues have been long resolved.

There is a difference between lying and inexperience/naïveté. Apparently, this is the first public entity in which these individuals have held positions. On-the-job training.

Facts are for investors.

Welcome to the cutting edge of drug development.